We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Radiotherapy Treatment Demonstrated for Kidney Cancer Patients

By MedImaging International staff writers
Posted on 15 May 2017
Print article
Image: A recent study showed stereotactic radiation is highly effective for kidney cancer (Photo courtesy of the University of Texas Southwestern Medical Center).
Image: A recent study showed stereotactic radiation is highly effective for kidney cancer (Photo courtesy of the University of Texas Southwestern Medical Center).
The results of a recent study have shown that using stereotactic ablative radiation therapy as an alternative to traditional kidney cancer patients, can achieve more than 90% percent control of metastases.

Traditional treatment for metastatic renal cell carcinoma includes targeted drugs, or immunotherapy, and other system therapies, which have significant side effects.

The study was carried out by researchers at the University of Texas (UT) Southwestern Medical Center’s Kidney Cancer Program of the Harold C. Simmons Comprehensive Cancer Center. The study was published in the May 1, 2017, issue of the journal International Journal of Radiation Oncology, Biology, and Physics.

According to the researchers, the study demonstrates that some kidney cancer patients could even be cured using stereotactic radiation therapy, or alternatively systemic therapy could be delayed saving patients from the side effects of immunotherapy drugs.

In the US, five-year survival rates for stage 1 kidney cancer are 81%, for stage 3 approximately 53%, and for patients with stage 4 cancer only 8%. On the other hand five-year survival rates of patients with stage 4 kidney cancer treated at the UT Southwestern Kidney Cancer Program are double the US national benchmarks.

Senior author of the study and co-leader of the Kidney Cancer Program, Assistant Professor of Radiation Oncology, Dr. Raquibul Hannan, said, “This study shows that stereotactic radiation provides a good non-invasive alternative to conventional treatment, and that it effectively controls the disease. It may also offer an alternative to patients who are not candidates for surgery due to the number and location of the metastases.”

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
X-Ray Meter
Cobia SENSE
New
Ultrasound Needle Guide
Ultra-Pro II
New
PACS Workstation
CHILI Web Viewer

Print article

Channels

Ultrasound

view channel
Image: Structure of the proposed transparent ultrasound transducer and its optical transmittance (Photo courtesy of POSTECH)

Ultrasensitive Broadband Transparent Ultrasound Transducer Enhances Medical Diagnosis

The ultrasound-photoacoustic dual-modal imaging system combines molecular imaging contrast with ultrasound imaging. It can display molecular and structural details inside the body in real time without... Read more

Nuclear Medicine

view channel
Image: PET/CT of a 60-year-old male patient with clinical suspicion of lung cancer (Photo courtesy of EJNMMI Physics)

Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times

F-18 FDG-PET scans are a way to look inside the body using a special dye, and these scans can be either static or dynamic. Static scans happen 60 minutes after the dye is administered into the body, showing... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The acquisition will expand IBA’s medical imaging quality assurance offering (Photo courtesy of Radcal)

IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering

Ion Beam Applications S.A. (IBA, Louvain-La-Neuve, Belgium), the global leader in particle accelerator technology and a world-leading provider of dosimetry and quality assurance (QA) solutions, has entered... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.